DF

David Fuller

Resonance Health Limited | Non-Executive Director
Dr Fuller is pharmaceutical physician and pharmacist with 30 years of experience across drug development, clinical research, regulatory strategy and commercialisation. He is currently Chief Medical Officer of Dimerix Limited. He held senior roles at Genzyme and Orphan Medical.

Company and Role

Company
Title
Tenure
Since
RHT
RHT
Resonance Health Limited
  • Non-Executive Director
1mthApr 2026

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RHT
RHT
Resonance Health Limited
22/05/26098,701N/AN/A
1AD
1AD
29/11/250491,5601,848,312N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RHT
RHT
Resonance Health Limited
22/05/26
Buy
98,701$0.040$3,962On-market trade
1AD
1AD
04/06/25
Issued
333,330$0.003$999Rights issue
1AD
1AD
04/06/25
Issued
166,665$0.003$499Rights issue
1AD
1AD
19/12/23
Issued
1,750,000$0.013$22,092Issue of options
1AD
1AD
29/05/23
Transfer
210,668$0.024$5,056Off-market transfer